Parmax Pharma Ltd.

BSE: 540359

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

106.75+2.1 (+1.96%)

7 Aug, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Parmax Pharma Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	—
Quarterly Results	—	—	—	—	—	Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Dec	Mar
Conference Calls	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Presentations	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Corporate Announcements and Regulatory Filings

Parmax Pharma Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Open Offer29 Jul 2026
Updates on Open Offer
Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of newspaper publication of Offer Opening Pre-Offer Advertisement to the Public Shareholders of Parmax Pharma ....
Open Offer27 Jul 2026
Updates on Open Offer
Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of newspaper publication of Recommendations of the Committee of Independent Directors ('IDC') to the Public ....
General22 Jul 2026
Letter of Offer
Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Public Shareholders of Parmax Pharma Ltd ("Target Company").
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201816 Jul 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate for quarter ended June 30, 2026
EGM3 Jul 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Scrutinizer report along with result of Evoting
Amendments to Memorandum & Articles of Association2 Jul 2026
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Amendments to Memorandum Of Association and Articles of Association of the Company
EGM2 Jul 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Scrutinizer Report and Voting Results
EGM2 Jul 2026
Shareholder Meeting / Postal Ballot-Outcome of EGM
Proceeding of 2nd Extra Ordinary General Meeting of the Company
Closure of Trading Window29 Jun 2026
Closure of Trading Window
Trading window closure
Newspaper Publication25 Jun 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication with respect to Corrigendum to EGM Notice
EGM23 Jun 2026
Corrigendum To The Notice Of (2Nd/2026-27) Extraordinary General Meeting Of The Company
Corrigendum to the EGM Notice dated 8th June 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201123 Jun 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pradeep Ramniklal Gosalia
General23 Jun 2026
Draft Letter of Offer
Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer for the attention of the Public Shareholders of Parmax Pharma Ltd ("Target Company").
Disclosures under Reg. 18(6) of SEBI (SAST) Regulations, 201119 Jun 2026
Disclosures under Reg. 18(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 18(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sunil Chinubhai Shah & Dhiren Shah
Disclosures under Reg. 18(6) of SEBI (SAST) Regulations, 201117 Jun 2026
Disclosures under Reg. 18(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 18(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhiren Chandulal Shah, Sunil Chinubhai Shah & PACs
General15 Jun 2026
Detailed Public Statement
Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulations 3(1) and 4 read with Regulations 13(4), 14 (3) and 15(2) ....
Newspaper Publication11 Jun 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Regarding Notice of EGM and E-voting
EGM9 Jun 2026
EGM Scheduled To Be Held On July 02, 2026
Notice of EGM scheduled to be held on July 02, 2026
Memorandum of Understanding /Agreements9 Jun 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Share purchase agreement and Public Announcement
Open Offer9 Jun 2026
Open Offer
Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Public Announcement under Regulation 3(1) And Regulation 4 Read with Regulation 13, Regulation 14 And Regulation ....

Frequently Asked Questions

Where can I download the annual report of Parmax Pharma Ltd.?

Annual reports of Parmax Pharma Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Parmax Pharma Ltd.?

Quarterly earnings results and presentations of Parmax Pharma Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Parmax Pharma Ltd. publish earnings call transcripts?

Earnings call transcripts of Parmax Pharma Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Parmax Pharma Ltd.?

Investor presentations and annual day presentations of Parmax Pharma Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Parmax Pharma Ltd.?

Corporate announcements and regulatory filings of Parmax Pharma Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Parmax Pharma Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Parmax Pharma Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Parmax Pharma Ltd.?

The ISIN (International Securities Identification Number) of Parmax Pharma Ltd. is INE240T01014. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Parmax Pharma Ltd. listed?

Parmax Pharma Ltd. is listed on NSE and BSE. The NSE symbol is PARMAX and the BSE code is -.

Where can I find the shareholding pattern of Parmax Pharma Ltd.?

The quarterly shareholding pattern of Parmax Pharma Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Parmax Pharma Ltd. on Sharpely?

Share price data for Parmax Pharma Ltd. is updated as of 7 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.